A Study to Evaluate the Efficacy and Safety of AD-223

NCT06052748 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

502

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension,Essential

Interventions

DRUG: AD-223A
DRUG: AD-223B
DRUG: AD-223C
DRUG: AD-223A Placebo
DRUG: AD-223B Placebo
DRUG: AD-223C Placebo

Sponsor

Addpharma Inc.